Indication
Herpes, Genital
5 clinical trials
10 products
Product
mRNA-1608Product
BEXSEROClinical trial
A Phase 1/2, Randomized, Observer-Blind, Controlled, Dose-Ranging Study of mRNA-1608, an HSV-2 Therapeutic Candidate Vaccine, in Healthy Adults 18 to 55 Years of Age With Recurrent HSV-2 Genital HerpesStatus: Active (not recruiting), Estimated PCD: 2025-06-04
Clinical trial
A Double-blind, Double Dummy, Randomized Crossover Trial to Compare the Effect of "AIC316 (Pritelivir)" 100 mg Once Daily Versus Valacyclovir 500 mg Once Daily on Genital HSV Shedding in HSV-2 Seropositive Adults.Status: Terminated, Estimated PCD: 2013-05-01
Product
ValacyclovirProduct
AIC316Product
UB-621Clinical trial
A Two-Stage, Randomized, Double-Blind, Dose-Ranging, Phase 2 Trial to Evaluate the Safety and Efficacy of UB-621 on HSV Shedding in Adults With Recurrent Genital HSV-2 Infection.Status: Not yet recruiting, Estimated PCD: 2024-06-30
Clinical trial
Safety and Efficacy of 4 Investigational HSV 2 Vaccines Administered by Intramuscular Route in Adults With Recurrent Genital Herpes Caused by HSV 2Status: Terminated, Estimated PCD: 2021-05-19
Product
HSV 2Product
HSV 2 FormulationProduct
HSV 2 Formulation 2Product
Sodium ChlorideClinical trial
Effect of Suppressive Therapy on Behavioral Determinants of HSV-2 TransmissionStatus: Terminated, Estimated PCD: 2010-06-01
Product
acyclovir